GEODE CAPITAL MANAGEMENT, LLC - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 35 filers reported holding CANCER GENETICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q3 2019$22,000
-38.9%
221,8030.0%0.00%
Q2 2019$36,000
-32.1%
221,8030.0%0.00%
Q1 2019$53,000
-50.0%
221,803
-50.0%
0.00%
Q4 2018$106,000
-4.5%
443,606
+313.2%
0.00%
Q3 2018$111,000
+16.8%
107,3550.0%0.00%
Q2 2018$95,000
-34.0%
107,355
+23.0%
0.00%
Q1 2018$144,000
-10.6%
87,2790.0%0.00%
Q4 2017$161,000
-31.5%
87,2790.0%0.00%
Q3 2017$235,000
-31.7%
87,2790.0%0.00%
Q2 2017$344,000
+3.0%
87,279
+7.0%
0.00%
Q1 2017$334,000
+507.3%
81,565
+97.8%
0.00%
Q4 2016$55,000
-23.6%
41,2430.0%0.00%
Q3 2016$72,000
-12.2%
41,2430.0%0.00%
Q2 2016$82,000
-29.9%
41,2430.0%0.00%
Q1 2016$117,000
-14.0%
41,2430.0%0.00%
Q4 2015$136,000
-58.8%
41,243
-2.4%
0.00%
Q3 2015$330,000
-33.5%
42,242
+0.1%
0.00%
Q2 2015$496,000
+59.0%
42,180
+5.5%
0.00%
Q1 2015$312,000
+17.3%
39,968
+0.2%
0.00%
Q4 2014$266,000
-25.7%
39,875
+0.2%
0.00%
Q3 2014$358,000
-20.1%
39,782
+0.2%
0.00%
Q2 2014$448,000
-25.2%
39,720
-0.1%
0.00%
Q1 2014$599,000
+56.0%
39,751
+42.6%
0.00%
Q4 2013$384,000
+67.7%
27,876
+146.4%
0.00%
Q3 2013$229,00011,3150.00%
Other shareholders
CANCER GENETICS INC shareholders Q2 2014
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 581,200$1,157,0001.33%
Fairbanks Capital Management, Inc. 233,170$464,0000.56%
DIKER MANAGEMENT LLC 29,815$59,0000.02%
SABBY MANAGEMENT, LLC 199,580$397,0000.02%
Sterneck Capital Management, LLC 14,750$29,0000.02%
Spot Trading L.L.C 151,900$302,0000.01%
Acrospire Investment Management LLC 3,514$7,0000.01%
EAGLE GLOBAL ADVISORS LLC 84,320$168,0000.01%
BECK MACK & OLIVER LLC 18,225$36,0000.00%
TOCQUEVILLE ASSET MANAGEMENT L.P. 47,600$94,0000.00%
View complete list of CANCER GENETICS INC shareholders